Nathalie Conte

Nathalie Conte

Auto-generated profile, based on publicly available information

Nathalie Conte

Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2010 in Science
Verified
Journal Article
Closed access
PDF file
RRRoland Rad
Roland Rad
LRLena Rad
Lena Rad
WWWei Wang
Wei Wang
JCJuan Cadiñanos
Juan Cadiñanos
GVGeorge Vassiliou
George Vassiliou
ABAllan Bradley
Allan Bradley
Piggybacking on Cancer Genes: Transposons are mobile segments of DNA that can insert in or near important genes to cause mutations that disrupt gene function. Rad et al. (p. 1104 , published online 14 October) adapted a mutagenic transposon called Piggybac, originally derived from a moth, into a tool for discovery of cancer-causing genes in mice. Mobilization of Piggybac in mice was associated with the development of leukemias and solid tumors. In many instances the causative mutations, which were identified by mapping the Piggybac integration sites, were within genes not previously implicated in cancer.

2 September 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
FFFloris Foijer
Floris Foijer
SXStephanie Z. Xie
Stephanie Z. Xie
JSJudith E. Simon
Judith E. Simon
PBPetra L. Bakker
Petra L. Bakker
NCNathalie Conte
Nathalie Conte
PSPeter K. Sorger
Peter K. Sorger
Aneuploidy is a hallmark of human solid cancers that arises from errors in mitosis and results in gain and loss of oncogenes and tumor suppressors. Aneuploidy poses a growth disadvantage for cells grown in vitro, suggesting that cancer cells adapt to this burden. To understand better the consequences of aneuploidy in a rapidly proliferating adult tissue, we engineered a mouse in which chromosome instability was selectively induced in T cells. A flanked by Lox mutation was introduced into the monopolar spindle 1 (Mps1) spindle-assembly checkpoint gene so that Cre-mediated recombination would create a truncated protein (Mps1DK) that retained the kinase domain but lacked the kinetochore-binding domain and thereby weakened the checkpoint. In a sensitized p53+/− background we observed that Mps1DK/DK mice suffered from rapid-onset acute lymphoblastic lymphoma. The tumors were highly aneuploid and exhibited a metabolic burden similar to that previously characterized in aneuploid yeast and cultured cells. The tumors nonetheless grew rapidly and were lethal within 3–4 mo after birth. Significance Normal cells rarely missegregate chromosomes, but the majority of cancer cells have a chromosomal instability (CIN) phenotype that makes errors more common and results in abnormal chromosomal content (aneuploidy). Although aneuploidy promotes transformation via gain of oncogenes and loss of tumor suppressors, it also slows cell proliferation and disrupts metabolic homeostasis. Aneuploidy therefore represents a liability as well as a source of selective advantage for cancer cells. We provoked CIN in murine T cells by weakening the spindle-assembly checkpoint and then studied the consequences. We found that CIN dramatically accelerates cancer in a genetically predisposed background and that the resulting aneuploid cancers are metabolically deranged, a vulnerability that may open new avenues to treating aneuploid cancers.

29 June 2017 in PLOS Biology
Verified
Journal Article
Open access
PDF file
JMJulie A. McMurry
Julie A. McMurry
NJNick Juty
Nick Juty
NBNiklas Blomberg
Niklas Blomberg
TBTony Burdett
Tony Burdett
TCTom Conlin
Tom Conlin
HPHelen Parkinson
Helen Parkinson
In many disciplines, data are highly decentralized across thousands of online databases (repositories, registries, and knowledgebases). Wringing value from such databases depends on the discipline of data science and on the humble bricks and mortar that make integration possible; identifiers are a core component of this integration infrastructure. Drawing on our experience and on work by other groups, we outline 10 lessons we have learned about the identifier qualities and best practices that facilitate large-scale data integration. Specifically, we propose actions that identifier practitioners (database providers) should take in the design, provision and reuse of identifiers. We also outline the important considerations for those referencing identifiers in various circumstances, including by authors and data generators. While the importance and relevance of each lesson will vary by context, there is a need for increased awareness about how to avoid and manage common identifier problems, especially those related to persistence and web-accessibility/resolvability. We focus strongly on web-based identifiers in the life sciences; however, the principles are broadly relevant to other disciplines.

21 February 2013 in Blood
Verified
Journal Article
Open access
PDF file
ODOliver M. Dovey
Oliver M. Dovey
CFCharles T. Foster
Charles T. Foster
NCNathalie Conte
Nathalie Conte
SESally A. Edwards
Sally A. Edwards
JEJennifer M. Edwards
Jennifer M. Edwards
SCShaun M. Cowley
Shaun M. Cowley
Key Points: We demonstrate a critical role for histone deacetylase 1 and 2 (HDAC1/2) in T-cell development and the maintenance of genomic stability.

1 October 2002 in The American Journal of Pathology
Verified
Journal Article
Closed access
CGChristophe Ginestier
Christophe Ginestier
ECEmmanuelle Charafe-Jauffret
Emmanuelle Charafe-Jauffret
FBFrançois Bertucci
François Bertucci
FEFrançois Eisinger
François Eisinger
JGJeannine Geneix
Jeannine Geneix
JJJocelyne Jacquemier
Jocelyne Jacquemier

7 April 2016 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
FRFoad J. Rouhani
Foad J. Rouhani
SNSerena Nik-Zainal
Serena Nik-Zainal
AWArthur Wuster
Arthur Wuster
YLYilong Li
Yilong Li
NCNathalie Conte
Nathalie Conte
ABAllan Bradley
Allan Bradley
The accuracy of replicating the genetic code is fundamental. DNA repair mechanisms protect the fidelity of the genome ensuring a low error rate between generations. This sustains the similarity of individuals whilst providing a repertoire of variants for evolution. The mutation rate in the human genome has recently been measured to be 50–70 de novo single nucleotide variants (SNVs) between generations. During development mutations accumulate in somatic cells so that an organism is a mosaic. However, variation within a tissue and between tissues has not been analysed. By reprogramming somatic cells into induced pluripotent stem cells (iPSCs), their genomes and the associated mutational history are captured. By sequencing the genomes of polyclonal and monoclonal somatic cells and derived iPSCs we have determined the mutation rates and show how the patterns change from a somatic lineage in vivo through to iPSCs. Somatic cells have a mutation rate of 14 SNVs per cell per generation while iPSCs exhibited a ten-fold lower rate. Analyses of mutational signatures suggested that deamination of methylated cytosine may be the major mutagenic source in vivo, whilst oxidative DNA damage becomes dominant in vitro. Our results provide insights for better understanding of mutational processes and lineage relationships between human somatic cells. Furthermore it provides a foundation for interpretation of elevated mutation rates and patterns in cancer. The mutation load of human tissues is unknown and represents the genetic divergence from the fertilised egg. Reprogramming of somatic cells generates induced pluripotent stem cells (iPSCs), a cell type being considered for clinical applications. We generated iPSCs from tissues of healthy individuals and used whole genome sequencing to identify in vivo mutations accrued in a somatic cell during the lifetime of the individual. Next we identified in vitro mutations introduced during reprogramming and cell culture. Each has a unique mutation signature suggesting different mutagenic processes. Our study demonstrates the use of reprogramming as a tool to elucidate mutational processes within normal cells and highlights the importance of genetic characterisation of iPSCs prior to clinical translation.